David L. Gibbs

Dr. David L. Gibbs

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
JHJulija Hmeljak
Julija Hmeljak
FSFrancisco Sanchez-Vega
Francisco Sanchez-Vega
KHKatherine A Hoadley
Katherine A Hoadley
JSJuliann Shih
Juliann Shih
CSChip Stewart
Chip Stewart
MLMarc Ladanyi
Marc Ladanyi
Malignant pleural mesothelioma (MPM) is a highly lethal cancer of the lining of the chest cavity. To expand our understanding of MPM, we conducted a comprehensive integrated genomic study, including the most detailed analysis of BAP1 alterations to date. We identified histology-independent molecular prognostic subsets, and defined a novel genomic subtype with TP53 and SETDB1 mutations and extensive loss of heterozygosity. We also report strong expression of the immune-checkpoint gene VISTA in epithelioid MPM, strikingly higher than in other solid cancers, with implications for the immune response to MPM and for its immunotherapy. Our findings highlight new avenues for further investigation of MPM biology and novel therapeutic options. Significance: Through a comprehensive integrated genomic study of 74 MPMs, we provide a deeper understanding of histology-independent determinants of aggressive behavior, define a novel genomic subtype with TP53 and SETDB1 mutations and extensive loss of heterozygosity, and discovered strong expression of the immune-checkpoint gene VISTA in epithelioid MPM. See related commentary by Aggarwal and Albelda, p. 1508. This article is highlighted in the In This Issue feature, p. 1494

1 April 2018 in Cell
Verified
Journal Article
Open access
LDLi Ding
Li Ding
MBMatthew H. Bailey
Matthew H. Bailey
EPEduard Porta-Pardo
Eduard Porta-Pardo
VTVesteinn Thorsson
Vesteinn Thorsson
ACAntonio Colaprico
Antonio Colaprico
AMArmaz Mariamidze
Armaz Mariamidze
The Cancer Genome Atlas (TCGA) has catalyzed systematic characterization of diverse genomic alterations underlying human cancers. At this historic junction marking the completion of genomic characterization of over 11,000 tumors from 33 cancer types, we present our current understanding of the molecular processes governing oncogenesis. We illustrate our insights into cancer through synthesis of the findings of the TCGA PanCancer Atlas project on three facets of oncogenesis: (1) somatic driver mutations, germline pathogenic variants, and their interactions in the tumor; (2) the influence of the tumor genome and epigenome on transcriptome and proteome; and (3) the relationship between tumor and the microenvironment, including implications for drugs targeting driver events and immunotherapies. These results will anchor future characterization of rare and common tumor types, primary and relapsed tumors, and cancers across ancestry groups and will guide the deployment of clinical genomic sequencing.

29 August 2016 in Bioinformatics
Verified
Journal Article
Open access
PDF file
WPWilliam Poole
William Poole
DGDavid L. Gibbs
David L. Gibbs
ISIlya Shmulevich
Ilya Shmulevich
BBBrady Bernard
Brady Bernard
TKTheo A Knijnenburg
Theo A Knijnenburg
Motivation: Combining P -values from multiple statistical tests is a common exercise in bioinformatics. However, this procedure is non-trivial for dependent P -values. Here, we discuss an empirical adaptation of Brown’s method (an extension of Fisher’s method) for combining dependent P -values which is appropriate for the large and correlated datasets found in high-throughput biology. Results : We show that the Empirical Brown’s method (EBM) outperforms Fisher’s method as well as alternative approaches for combining dependent P -values using both noisy simulated data and gene expression data from The Cancer Genome Atlas. Availability and Implementation : The Empirical Brown’s method is available in Python, R, and MATLAB and can be obtained from https://github.com/IlyaLab/CombiningDependentPvalues UsingEBM . The R code is also available as a Bioconductor package from https://www.bioconductor.org/packages/devel/bioc/html/EmpiricalBrownsMethod.html . Contact:Theo.Knijnenburg@systemsbiology.org Supplementary information:Supplementary data are available at Bioinformatics online.

4 March 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
TKTheo A. Knijnenburg
Theo A. Knijnenburg
JVJoseph G. Vockley
Joseph G. Vockley
NCNyasha Chambwe
Nyasha Chambwe
DGDavid L. Gibbs
David L. Gibbs
CHCrystal Humphries
Crystal Humphries
JNJohn E. Niederhuber
John E. Niederhuber
Significance: Preterm birth (PTB) complications are the leading cause of long-term morbidity and mortality in children. The genetic and molecular characteristics of PTB and related disorders remain unclear. In this study, a family-based cohort of 791 family trios, including 270 PTB and 521 control families, was investigated by using whole-genome sequencing, RNA sequencing, and DNA methylation data. Integrative analysis identified 160 genomic variants associated with PTB-related phenotypes and led to the discovery of 72 candidate biomarker genes for very early PTB (VEPTB). The genes associated with VEPTB involve growth signaling and inflammation- and immunity-related pathways. With these data, and by stratifying PTB by subphenotype, we have identified PTB genes and pathways that can be used as a starting point in further clinical studies.

31 October 2017 in Cancer Research
Verified
Journal Article
Closed access
PDF file
SRSheila M. Reynolds
Sheila M. Reynolds
MMMichael Miller
Michael Miller
PLPhyliss Lee
Phyliss Lee
KLKalle Leinonen
Kalle Leinonen
SPSuzanne M. Paquette
Suzanne M. Paquette
Ilya ShmulevichIlya Shmulevich
Ilya Shmulevich
The ISB Cancer Genomics Cloud (ISB-CGC) is one of three pilot projects funded by the National Cancer Institute to explore new approaches to computing on large cancer datasets in a cloud environment. With a focus on Data as a Service, the ISB-CGC offers multiple avenues for accessing and analyzing The Cancer Genome Atlas, TARGET, and other important references such as GENCODE and COSMIC using the Google Cloud Platform. The open approach allows researchers to choose approaches best suited to the task at hand: from analyzing terabytes of data using complex workflows to developing new analysis methods in common languages such as Python, R, and SQL; to using an interactive web application to create synthetic patient cohorts and to explore the wealth of available genomic data. Links to resources and documentation can be found at www.isb-cgc.org. Cancer Res; 77(21); e7–10. ©2017 AACR.

1 January 2013 in Journal of Clinical Bioinformatics
Verified
Journal Article
Open access
PDF file
DGDavid L. Gibbs
David L. Gibbs
ABArie Baratt
Arie Baratt
RBRalph S. Baric
Ralph S. Baric
YKYoshihiro Kawaoka
Yoshihiro Kawaoka
RSRichard Smith
Richard Smith
SMShannon K McWeeney
Shannon K McWeeney
Background Biological networks are important for elucidating disease etiology due to their ability to model complex high dimensional data and biological systems. Proteomics provides a critical data source for such models, but currently lacks robust de novo methods for network construction, which could bring important insights in systems biology. Results We have evaluated the construction of network models using methods derived from weighted gene co-expression network analysis (WGCNA). We show that approximately scale-free peptide networks, composed of statistically significant modules, are feasible and biologically meaningful using two mouse lung experiments and one human plasma experiment. Within each network, peptides derived from the same protein are shown to have a statistically higher topological overlap and concordance in abundance, which is potentially important for inferring protein abundance. The module representatives, called eigenpeptides, correlate significantly with biological phenotypes. Furthermore, within modules, we find significant enrichment for biological function and known interactions (gene ontology and protein-protein interactions). Conclusions Biological networks are important tools in the analysis of complex systems. In this paper we evaluate the application of weighted co-expression network analysis to quantitative proteomics data. Protein co-expression networks allow novel approaches for biological interpretation, quality control, inference of protein abundance, a framework for potentially resolving degenerate peptide-protein mappings, and a biomarker signature discovery.